As the use of artificial intelligence becomes a more popular tool in drug research, a scientific software company aims to one ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat ...

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday.

The artificial intelligence in drug discovery market represents a transformative frontier in pharmaceutical research, ...

The open-source pipeline designs proteins with improved success rates for therapeutic targets, including gene editing proteins and allergens.

Artificial Intelligence has been used to design two new antibiotics that have the potential to fight against drug-resistant ...

For AI tools making high-stakes clinical decisions, well-designed, prospective RCTs must be the gold standard.

Overview Advanced tools are creating entirely new antibiotics to fight infections like MRSA and drug-resistant gonorrhoea.Millions of molecules can be tested vi ...

Isomorphic will use the windfall to fund development of its next-generation artificial intelligence drug design model, the company announced in a March 31 release. The AI biotech is also looking ...

Researchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including ...

We review use of artificial intelligence-based technologies in oncology clinical trials, with potential to improve patient recruitment and stratification, trial design and operations, and data mana ...